| Selected Balance Sheet Data |
Note 3. Selected Balance Sheet Data:
Inventories:
Inventories consist of (in thousands):
|
|
|
|
|
|
|
|
|
|
March 31, |
|
June 30, |
|
|
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
|
Raw materials |
|
$ |
83,453 |
|
$ |
79,377 |
|
Finished goods(1) |
|
|
113,310 |
|
|
106,072 |
|
Inventories, net |
|
$ |
196,763 |
|
$ |
185,449 |
|
(1) Finished goods inventory of $5,680 and $5,718 is included within Other long-term assets in the respective March 31, 2025 and June 30, 2024. The inventory is included in long-term assets as it is forecasted to be sold after the 12 months subsequent to the Condensed Consolidated Balance Sheet date.
Property and Equipment:
Property and equipment consist of (in thousands):
|
|
|
|
|
|
|
|
|
|
March 31, |
|
June 30, |
|
|
|
2025 |
|
2024 |
|
Land |
|
$ |
8,105 |
|
$ |
8,150 |
|
Buildings and improvements |
|
|
249,896 |
|
|
243,863 |
|
Machinery and equipment |
|
|
240,948 |
|
|
215,948 |
|
Construction in progress |
|
|
31,819 |
|
|
39,749 |
|
Property and equipment, cost |
|
|
530,768 |
|
|
507,710 |
|
Accumulated depreciation and amortization |
|
|
(278,791) |
|
|
(256,556) |
|
Property and equipment, net |
|
$ |
251,977 |
|
$ |
251,154 |
|
Intangible Assets:
Intangible assets consist of (in thousands):
|
|
|
|
|
|
|
|
|
|
March 31, |
|
June 30, |
|
|
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
|
Developed technology |
|
$ |
677,236 |
|
$ |
675,674 |
|
Tradenames |
|
|
151,378 |
|
|
151,561 |
|
Customer relationships |
|
|
211,480 |
|
|
211,276 |
|
Patents |
|
|
4,829 |
|
|
4,343 |
|
Other intangibles |
|
|
7,162 |
|
|
12,006 |
|
Definite-lived intangible assets |
|
|
1,052,085 |
|
|
1,054,860 |
|
Accumulated amortization |
|
|
(608,386) |
|
|
(547,779) |
|
Total intangible assets, net |
|
$ |
443,699 |
|
$ |
507,081 |
|
Changes to the carrying amount of net intangible assets for the period ended March 31, 2025 consist of (in thousands):
|
|
|
|
|
|
March 31, |
|
|
2025 |
|
|
|
|
Beginning balance |
|
$ |
507,081 |
Other additions |
|
|
364 |
Amortization expense |
|
|
(57,714) |
Restructuring impairment |
|
|
(7,050) |
Currency translation |
|
|
1,018 |
Ending balance |
|
$ |
443,699 |
The estimated future amortization expense for intangible assets as of March 31, 2025 is as follows (in thousands):
|
|
|
|
Remainder 2025 |
|
$ |
18,889 |
2026 |
|
|
72,497 |
2027 |
|
|
62,326 |
2028 |
|
|
58,616 |
2029 |
|
|
46,049 |
Thereafter |
|
|
185,322 |
Total |
|
$ |
443,699 |
Goodwill:
Changes to the carrying amount of goodwill for the period ended March 31, 2025 consist of (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diagnostics and |
|
|
|
|
Protein Sciences |
|
Spatial Biology |
|
Total |
June 30, 2024 |
|
$ |
423,449 |
|
$ |
549,214 |
|
$ |
972,663 |
Currency translation |
|
|
(2,334) |
|
|
(1,717) |
|
|
(4,051) |
March 31, 2025 |
|
$ |
421,115 |
|
$ |
547,497 |
|
$ |
968,612 |
We evaluate the carrying value of goodwill in the fourth quarter of each fiscal year and between annual evaluations if events occur or circumstances change that would indicate a possible impairment. The Company performed a qualitative goodwill impairment assessment for all of its reporting units during the fourth quarter of fiscal 2024. No indicators of impairment were identified as part of our assessment.
Other Assets:
Other assets consist of (in thousands):
|
|
|
|
|
|
|
|
|
March 31, |
|
June 30, |
|
|
2025 |
|
2024 |
|
|
|
|
|
|
|
Equity method investment in Wilson Wolf |
|
$ |
239,515 |
|
$ |
242,337 |
Derivative instruments |
|
|
0 |
|
|
9,813 |
Long-term inventory |
|
|
5,680 |
|
|
5,718 |
Investment in Spear Bio |
|
|
15,000 |
|
|
— |
Other |
|
|
8,792 |
|
|
6,397 |
Other assets |
|
$ |
268,987 |
|
$ |
264,265 |
|